BUD vs MO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite this, the stock trades above its Graham Number of $52.90 at $69.88, supported by a bullish analyst recommendation and strong recent price performance. Earnings growth has collapsed year-over-year (-48.6%), yet the company consistently beats estimates, showing some earnings quality. Profit margins and cash flow generation remain solid, but missing key financial health metrics like ROE, ROA, and Altman Z-Score limits confidence in stability. The dividend is sustainable with a 37.5% payout ratio, but insider sentiment and technical trend are weak.
Altria Group presents a precarious financial profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect. The stock is trading at $68.20, which is significantly above its growth-based intrinsic value of $28.84. Most concerning is the dividend payout ratio of 100.97%, indicating that the dividend is currently unsustainable based on earnings. Combined with negative revenue and earnings growth, the company appears to be in a value-trap scenario despite its high profit margins.
Compare Another Pair
Related Comparisons
BUD vs MO: Head-to-Head Comparison
This page compares Anheuser-Busch InBev SA/NV (BUD) and Altria Group, Inc. (MO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.